Unknown PHASE4 INTERVENTIONAL 2-arm NCT00523289

Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block

Sponsor: Cristália Produtos Químicos Farmacêuticos Ltda.

Conditions Anesthesia Conduction Anesthetics, Local Injuries, Hand

Updated 5 times since 2017 Last updated: Feb 18, 2009 Started: Oct 31, 2007 Primary completion: Mar 31, 2009 Completion: Jul 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00523289, this PHASE4 trial focuses on Anesthesia Conduction and Anesthetics, Local and remains ongoing. Sponsored by Cristália Produtos Químicos Farmacêuticos Ltda., it has been updated 5 times since 2007, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Oct 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cristália Produtos Químicos Farmacêuticos Ltda.
University of Sao Paulo

Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.